EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Optical coherence tomography biomarkers in early and intermediate age‐related macular degeneration: A clinical guide

Lourdes Vidal-Oliver, Elena Montolío-Marzo, Roberto Gallego-Pinazo, Rosa Dolz-Marco iD

Clinical & Experimental Ophthalmology · 2024

DOI: 10.1111/ceo.14337 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical & Experimental Ophthalmology, 2024. Verfasst von Lourdes Vidal-Oliver und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Fundación Oftalmología Médica de la Comunidad Valenciana, Valencia, Spain. Hauptthemen laut MEDLINE: Retinal Drusen, Macular Degeneration, Geographic Atrophy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced forms of age‐related macular degeneration (AMD), characterised by atrophic and neovascular changes, are a leading cause of vision loss in the elderly population worldwide. Prior to the development of advanced AMD, a myriad of risk factors from the early and intermediate stages of AMD have been published in the scientific literature over the last years. The ability to precisely recognise structural and anatomical changes in the ageing macula, altogether with the understanding of the individual risk implications of each one of them is key for an accurate and personalised diagnostic assessment. The present review aims to summarise updated evidence of the relative risk conferred by diverse macular signs, commonly seen on optical coherence tomography, in terms of progression to geographic atrophy or macular neovascularization. This information may also serve as a basis for tailored follow‐up monitoring visits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal DrusenMacular DegenerationGeographic AtrophyHumansAgedTomography, Optical CoherenceBiomarkers

Stichwörter der Autor:innen

advanced age related macular degeneration AMDdrusenintermediate age related macular degenerationoptical coherence tomographysubretinal drusenoid deposits

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Ophthalmology, Fundación Oftalmología Médica de la Comunidad Valenciana, Valencia, Spain.
  • Department of Ophthalmology, Clínico San Carlos Hospital, Madrid, Spain.
  • Macula Unit, Oftalvist Clinic, Valencia, Spain.

ORCID-Profile: Rosa Dolz-Marco

Zitieren

APA

Vidal-Oliver, L., Montolío-Marzo, E., Gallego-Pinazo, R., & Dolz-Marco, R. (2024). Optical coherence tomography biomarkers in early and intermediate age‐related macular degeneration: A clinical guide. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14337

Vancouver

Vidal-Oliver L, Montolío-Marzo E, Gallego-Pinazo R, Dolz-Marco R. Optical coherence tomography biomarkers in early and intermediate age‐related macular degeneration: A clinical guide. Clinical & Experimental Ophthalmology. 2024. doi:10.1111/ceo.14337

BibTeX
@article{VidalOliver2024,
  author = {Vidal-Oliver, Lourdes and Montolío-Marzo, Elena and Gallego-Pinazo, Roberto and Dolz-Marco, Rosa},
  title = {Optical coherence tomography biomarkers in early and intermediate age‐related macular degeneration: A clinical guide},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2024},
  doi = {10.1111/ceo.14337}
}
Kostenlos starten →